BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1712242)

  • 1. Differences in the leucine aminopeptidase activity in extracts from human prostatic carcinoma and benign prostatic hyperplasia.
    Rackley RR; Yang B; Pretlow TG; Abdul-Karim FW; Lewis TJ; McNamara N; Delmoro CM; Bradley EL; Kursh E; Resnick MI
    Cancer; 1991 Aug; 68(3):587-93. PubMed ID: 1712242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5'-nucleotidase activity in prostatic carcinoma and benign prostatic hyperplasia.
    Rackley RR; Lewis TJ; Preston EM; Delmoro CM; Bradley EL; Resnick MI; Pretlow TP; Pretlow TG
    Cancer Res; 1989 Jul; 49(13):3702-7. PubMed ID: 2471588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Histochemical characterization of different tissue enzymes in prostate adenomas and carcinomas].
    Hajek J; Papousek F; Nemecek R; Hanselova M; Strmiska M
    Acta Urol Belg; 1985; 53(1):96-100. PubMed ID: 2581425
    [No Abstract]   [Full Text] [Related]  

  • 4. Leucine-arylamidase activity in untreated and treated benign prostatic hypertrophy and adenocarcinomatous prostate.
    Verlooy J; van Sande M; Van Camp K
    Acta Urol Belg; 1981 Oct; 49(4):491-5. PubMed ID: 6172970
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-glucuronidase activity in prostatic carcinoma and benign prostatic hyperplasia.
    Pearson JP; Pretlow TP; Bradley EL; McGinnis MC; Pretlow TG
    Cancer; 1989 Aug; 64(4):911-5. PubMed ID: 2472870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in serum acid and alkaline phosphatase and leucine aminopeptidase activities following massage of the prostate. Value in differentiating carcinoma from benign hyperplasia of the prostate.
    Ishibe T
    Int Urol Nephrol; 1972; 4(1):51-7. PubMed ID: 4131652
    [No Abstract]   [Full Text] [Related]  

  • 7. A histochemical study of glycosidases in benign prostatic hyperplasia and in prostatic carcinoma in the human.
    Sinowatz F; Weber P; Gasser G; Mossig H; Skolek-Winnisch R
    Urol Res; 1978; 6(2):103-7. PubMed ID: 78561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in creatine kinase in human prostatic carcinoma compared to benign prostatic hyperplasia.
    Pretlow TG; Whitehurst GB; Pretlow TP; Hunt RS; Jacobs JM; McKenzie DR; McDaniel HG; Hall LM; Bradley EL
    Cancer Res; 1982 Nov; 42(11):4842-8. PubMed ID: 6181869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma.
    Harris BE; Pretlow TP; Bradley EL; Whitehurst GB; Pretlow TG
    Cancer Res; 1983 Jun; 43(6):3008-12. PubMed ID: 6189588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid phosphatase in prostatic tissue homogenates from patients with benign prostatic hyperplasia and prostatic carcinoma.
    Copland GT; Whitehurst GB; Pretlow TP; Boohaker EA; Bartolucci AA; Pretlow TG
    Cancer; 1983 Jul; 52(1):155-60. PubMed ID: 6189580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Enzymological study of prostatic cancer. V. Alterations in the serum acid and alkaline phosphatase and leucine aminopeptidase activities following massage of the prostate].
    Ishibe T
    Nihon Hinyokika Gakkai Zasshi; 1972 Oct; 63(10):873-7. PubMed ID: 4119371
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
    Leav I; McNeal JE; Ho SM; Jiang Z
    Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear casein kinase 2 (CK-2) activity in human normal, benign hyperplastic, and cancerous prostate.
    Yenice S; Davis AT; Goueli SA; Akdas A; Limas C; Ahmed K
    Prostate; 1994; 24(1):11-6. PubMed ID: 7507238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic activities in extracts of small (20 +/- 5 mg) samples of prostatic carcinoma.
    Rackley RR; Lewis TJ; Bradley EL; Levin HS; Resnick MI; Pretlow TP; Pretlow TG
    Anal Biochem; 1990 Jan; 184(1):128-34. PubMed ID: 1690957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactate dehydrogenase isoenzymes in hyperplasia and carcinoma of the prostate: a clinical study.
    Elhilali MM; Oliver JA; Sherwin AL; Mackinnon KJ
    J Urol; 1967 Dec; 98(6):686-92. PubMed ID: 4169732
    [No Abstract]   [Full Text] [Related]  

  • 16. Study of activities of arginase, hexosaminidase, and leucine aminopeptidase in prostate fluid.
    Vafa AZ; Grover PK; Pretlow TG; Resnick MI
    Urology; 1993 Aug; 42(2):138-43. PubMed ID: 7690169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of galactosyltransferase in prostatic tumors.
    Amselgruber WM; Sinowatz F; Kölle S; Lincoln DT; Kayser K
    Nutrition; 1995; 11(5 Suppl):638-42. PubMed ID: 8748240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostatic hexosaminidase activity in patients with benign prostatic hyperplasia and prostatic carcinoma.
    Whitehurst GB; Mashburn JP; Pretlow TG; Bradley EL; Boohaker EA
    Cancer Res; 1982 Oct; 42(10):4300-3. PubMed ID: 6179600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia: correlation with Gleason's score, microvessel density, and epithelial cell proliferation.
    Vartanian RK; Weidner N
    Lab Invest; 1995 Dec; 73(6):844-50. PubMed ID: 8558846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme activities in prostatic carcinoma related to Gleason grades.
    Pretlow TG; Harris BE; Bradley EL; Bueschen AJ; Lloyd KL; Pretlow TP
    Cancer Res; 1985 Jan; 45(1):442-6. PubMed ID: 3155494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.